Related references
Note: Only part of the references are listed.An update on the role of leukotrienes in asthma
Teal S. Hallstrand et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?
Paul A. Lapchak
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Pranlukast Attenuates Ischemia-like Injury in Endothelial Cells Via Inhibiting Reactive Oxygen Species Production and Nuclear Factor-kappa B Activation
San-Hua Fang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Review of recent results of montelukast use as a monotherapy in children with mild asthma
Ulrich Wahn et al.
CLINICAL THERAPEUTICS (2008)
Cysteinyl leukotriene receptor CysLT(1) as a novel therapeutic target for allergic rhinitis treatment
Hideaki Shirasaki
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Down-Regulation of Neurocan Expression in Reactive Astrocytes Promotes Axonal Regeneration and Facilitates the Neurorestorative Effects of Bone Marrow Stromal Cells in the Ischemic Rat Brain
Li Hong Shen et al.
GLIA (2008)
Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation
Xiao-Jia Huang et al.
GLIA (2008)
Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma
Stanley J. Szefler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Mechanisms of disease: Leukotrienes
Marc Peters-Golden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends
Valerie Capra et al.
MEDICINAL RESEARCH REVIEWS (2007)
Pharmacological modulation of the leukotriene pathway in allergic airway disease
Paolo Montuschi et al.
DRUG DISCOVERY TODAY (2007)
Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats
Yu Zhou et al.
LIFE SCIENCES (2006)
Therapeutic strategies for the treatment of stroke
A. Richard Green et al.
DRUG DISCOVERY TODAY (2006)
Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons
QF Ge et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury
Hiroshi Yoshida et al.
CNS DRUG REVIEWS (2006)
Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice
LS Chu et al.
ACTA PHARMACOLOGICA SINICA (2006)
Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats
S. H. Fang et al.
NEUROSCIENCE (2006)
Short-term administration of a new free radical scavenger, edaravone, is more effective than its long-term administration for the treatment of neonatal hypoxic-ischemic encephalopathy
JI Noor et al.
STROKE (2005)
Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice
GL Yu et al.
BRAIN RESEARCH (2005)
Skilled reaching impairments from the lateral frontal cortex component of middle cerebral artery stroke: a qualitative and quantitative comparison to focal motor cortex lesions in rats
OA Gharbawie et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice
GL Yu et al.
PHARMACOLOGY (2005)
Pranlukast inhibits NF-kappa B activation and MUC2 gene expression in cultured human epithelial cells
H Ishinaga et al.
PHARMACOLOGY (2005)
Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism
C Fukushima et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway
R Ciccarelli et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Unilateral ischemic sensorimotor cortical damage in female rats: forelimb behavioral effects and dendritic structural plasticity in the contralateral homotopic cortex
RP Allred et al.
EXPERIMENTAL NEUROLOGY (2004)
Accelerated glial reactivity with reduced to stroke in aged rats correlates functional recovery
I Badan et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Pranlukast inhibits NF-κB activation in human monocytes/macrophages and T cells
T Ichiyama et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
International union of pharmacology - XXXVII. Nomenclature for leukotriene and lipoxin receptors
C Brink et al.
PHARMACOLOGICAL REVIEWS (2003)
L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice
L Ding-Zhou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia
L Zhang et al.
JOURNAL OF NEUROSCIENCE METHODS (2002)
Share Paper
